Narrative review / 2018
A review evaluates potential adverse effects of chronic PPI use, including vitamin B12 and iron deficiencies and other systemic harms.
This narrative review evaluates the safety and postulated harms associated with the chronic use of proton pump inhibitors (PPIs) for acid-related digestive diseases. Reported adverse events linked to chronic use include serum electrolyte alterations, vitamin B12 and iron deficiency, gastric tumors, enteric infections, spontaneous bacterial peritonitis, pneumonia, ischemic heart attacks, bone fractures, chronic kidney disease, dementia, and Alzheimer disease. The author notes that safety studies generally carry significant limitations, such as frequent retrospective designs, patient selection issues, and residual confounders.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Patients with acid-related digestive diseases
- What was measured
- Adverse events associated with proton pump inhibitor (PPI) use
THE PAPER
A safety review of proton pump inhibitors to treat acid-related digestive diseases.
Savarino E, Marabotto E, Zentilin P, Furnari M, Bodini G, Pellegatta G, Lorenzon G, Della Coletta M, Ghisa M, Coppo C, Marinelli C, Savarino V. Expert Opin Drug Saf, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.